Articles On Avita Medical (ASX:AVH)

Brokers review first quarter results and pending regulatory approvals for Avita Medical. -Avita Medical awaits near-term regulatory approvals-Potential Recell launch in the US for soft tissue repair-Early 2024 launch of Recell Go will reduc...

World Overnight SPI Overnight 7217.00 – 37.00 – 0.51% S&P ASX 200 7234.70 – 32.40 – 0.45% S&P500 4109.90 – 26.38 – 0.64% Nasdaq Comp 12343.05 – 22.16 – 0.18% DJIA 33012.14 – 336.46 – 1.01% S&P500 VIX 17.99 + 0.87 5...

Regenerative medical company AVITA Medical (ASX:AVH) has reported a 40 per cent increase in revenue for the first quarter of 2023.

After a feeble start, the benchmark has rallied to close at +0.1% Newcrest and Newmont shake hands on Australia’s biggest goldie takeover Westar Resources shines bright with a 47% price hike   As far as days on the ASX go, that definitely...

For the first day of the trading week, the market closed in the green at 7,267.10 points. In the Green Gold producer, Silver Lake Resources’ (SLR) price made a rebound, amid a battle to takeover fellow gold producer St Barbara’s Leo...

Stock in tiny lithium hopeful Lithium Energy Ltd (ASX: LEL) took off earlier today before plunging into the red on news of a massive find at the company’s Solaroz Brine Project. The project is located in Argentina, right next door to All...

It’s been a fairly lacklustre start to the trading week for most ASX shares so far this Monday. At the time of writing, the All Ordinaries Index (ASX: XAO) has fallen by 0.21%. But let’s talk about the plunging Avita Medical Inc. (ASX: AVH...

The Tyro Payments Ltd (ASX: TYR) share price has followed the All Ordinaries Index (ASX: XAO) lower today despite the payment solutions provider upgrading its full-year guidance. The upgrade came on the back of a strong 10-month period and...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

ASX health stocks rise in the past five days outperforming broader markets Avita Medical product sales up 40% on pcp to US$10.5 million in Q1 FY23 Proteomics International Laboratories inks a deal with Sonic Healthcare USA Healthcare and...

The ASX is set to fall today on renewed US banking crisis The BoE raised its rates to highest in 15 years Gold was down despite Wall Street selloff   The ASX is poised to open lower on Friday as the US banking crisis reared its ugly head...

Tim Boreham reports a change in CEO has given cancer monitoring biotech Impedimed a new lease of life. By Tim Boreham ASX code: ((IPD)) Share price: 18.5 cents Shares on issue: 1,787,664,914 Market cap: $330.7 million Chief executive office...

Investing in ASX shares has been a profitable venture for most investors in 2023. Since the opening bell on 3 January, the All Ordinaries Index (ASX: XAO) has gained 5%. And that figure doesn’t include any dividend payouts made by many o...

World Overnight SPI Overnight 7316.00 – 38.00 – 0.52% S&P ASX 200 7322.00 – 8.40 – 0.11% S&P500 4071.63 – 65.41 – 1.58% Nasdaq Comp 11799.16 – 238.05 – 1.98% DJIA 33530.83 – 344.57 – 1.02% S&P500 VIX 18.76 + 1.87 1...

By Mark Woodruff Guide: The FNArena database tabulates the views of eight major Australian and international stockbrokers: Citi, Bell Potter, Macquarie, Morgan Stanley, Morgans, Ord Minnett, Shaw and Partners and UBS. For the purpose of bro...

World Overnight SPI Overnight 7376.00 – 17.00 – 0.23% S&P ASX 200 7381.50 + 19.90 0.27% S&P500 4151.32 + 13.68 0.33% Nasdaq Comp 12157.72 + 34.26 0.28% DJIA 33987.18 + 100.71 0.30% S&P500 VIX 16.95 – 0.12 – 0.70%...

By Mark Woodruff Guide: The FNArena database tabulates the views of eight major Australian and international stockbrokers: Citi, Bell Potter, Macquarie, Morgan Stanley, Morgans, Ord Minnett, Shaw and Partners and UBS. For the purpose of bro...

ASX health stocks rise 0.97% in the past five days in line with broader markets Impedimed up 99% after BIS tech named in latest US NCCN guidelines for lymphoedema  EBR Systems to release top line results at cardiac conference Heart Rhythm...

Tim Boreham highlights the global addressable market opportunity for Avita Medical's skin graft technology, made famous by the Bali bombings. By Tim Boreham ASX code: AVH (Chess depositary instruments); Nasdaq code: RCEL (US shares) Shares...

Several ASX health stocks are seeking US FDA approval for drugs/devices in the near future Telix Pharmaceuticals is chasing renal cancer imaging approval for TLX-250 CDx Aroa is awaiting an FDA decision on the required regulatory pathway...

It’s been a pretty positive day for ASX shares and the All Ordinaries Index (ASX: XAO) so far this Thursday. After a rocky start, the All Ords is tentatively in the green at the time of writing, having put on 0.12%, which lifts the Index t...

World Overnight SPI Overnight 7272.00 – 60.00 – 0.82% S&P ASX 200 7364.70 + 36.10 0.49% S&P500 3986.37 – 62.05 – 1.53% Nasdaq Comp 11530.33 – 145.41 – 1.25% DJIA 32856.46 – 574.98 – 1.72% S&P500 VIX 19.59 + 0.98 5....

World Overnight SPI Overnight 7279.00 – 12.00 – 0.16% S&P ASX 200 7328.60 + 45.00 0.62% S&P500 4048.42 + 2.78 0.07% Nasdaq Comp 11675.74 – 13.27 – 0.11% DJIA 33431.44 + 40.47 0.12% S&P500 VIX 18.61 + 0.12 0.65% U...

By Mark Woodruff Guide: The FNArena database tabulates the views of seven major Australian and international stock brokers: Citi, Credit Suisse, Macquarie, Morgan Stanley, Morgans, Ord Minnett and UBS. For the purpose of broker rating corre...

World Overnight SPI Overnight 7177.00 – 21.00 – 0.29% S&P ASX 200 7258.40 + 33.60 0.47% S&P500 3970.15 – 12.09 – 0.30% Nasdaq Comp 11455.54 – 11.44 – 0.10% DJIA 32656.70 – 232.39 – 0.71% S&P500 VIX 20.70 – 0.25 – 1...

The ASX All Ordinaries Index (ASX: XAO) has had a bumpy few days of trading recently. Last Friday, the All Ords rose by a decent 0.3%, only to tank by a nasty 1.2% yesterday. Today so far, the Index has bounced back up by 0.48%. But let’s...

World Overnight SPI Overnight 7201.00 + 34.00 0.47% S&P ASX 200 7224.80 – 82.20 – 1.12% S&P500 3982.24 + 12.20 0.31% Nasdaq Comp 11466.98 + 72.04 0.63% DJIA 32889.09 + 72.17 0.22% S&P500 VIX 20.95 – 0.72 – 3.32%...

The ASX fell today because US data gave Wall Street the willies on Friday A month’s worth of shipping data shows coal shipments to China are on the rise Qantas celebrates last week’s $1bn profit by slashing regional services. Again   Toda...

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((ALG)) - Ardent Leisure ((ASB)) - Austal ((AFG)) - Australian Finance Group ((AVH)) - Avita Medical ((BRI)) - Big River Industries ((SQ2)) - Block ((BXB)) - Brambles ((CB...

ShareCafeFour sectors trading at least 1% higher; ASX up 0.35% at noon by Peter Milios   Industrials, Information Technology, Utilities and Real Estate are trading at least 1 per cent higher, responding to strong figures from the US markets...

24 Feb 2023 - A snapshot of the stocks on the move featuring Resource Base (ASX:RBX), AVITA Medical (ASX:AVH) and Selfwealth (ASX:SWF).

ShareCafeStocks of the Hour: RBX, AVH, SWF                    Resource Base (ASX:RBX) has secured an option to acquire two highly prospective lithium projects in Québec. Resource Base Non-Executive Chairman, Maurice Feilich, commented...

There are many ASX shares vying for a position in my portfolio at any single point in time. Companies that exhibit impressive revenue growth, sell incredibly valuable products/services, and are leaders in their fields. However, as amazing...

Morningstar sees ASX healthcare sector as fair value with some buying opportunities Healthcare stocks viewed as defensive and insulated from rising inflation Morningstar has several healthcare picks for 2023 with last year’s headwinds like...

“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o...

Regenerative medicine company AVITA Medical (ASX:AVH) has announced the submission of a Premarket Approval application to the US FDA for its RECELL System.

Jeremy Curnock Cook is the Managing Director and founder of BioScience Managers, a funds management business specialising in biotechnology investments in Australia and globally. He is also a director of Avita Medical Inc (ASX: AVH). Jeremy...

The All Ordinaries Index (ASX: XAO) fell 0.65% today, but three ASX shares charged higher. The Magnis Energy Technologies Ltd (ASX: MNS), Cettire Ltd (ASX: CTT) and Avita Medical Inc (ASX: AVH) share prices all outperformed the index tod...

Regenerative medicine company AVITA Medical (ASX:AVH) has submitted to the US FDA for premarket approval supplement application for its RECELL System.

Purpose focused startups such as Great Wrap, Bare Cremation, and Separation Guide, are among the major winners of the annual Pause Awards. Held in Melbourne and backed by VicGov, the 5th annual Pause Awards recognise innovation and people b...

Shares in the spray-on skin company Avita Medical Inc (ASX: AVH) closed 2.6% higher on Friday at $1.96. The ASX healthcare share may be down 42% over the year to date, but it appears to be making a comeback. The Avita share price is up a...

Ask A Fund Manager The Motley Fool chats with the best in the industry so that you can get an insight into how the professionals think. In this edition, Bell Direct market analyst Grady Wulff names two cheap ASX shares to buy and one to ho...

An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Au...

A global relief rally catapulted the ASX 200 to a five-month high after Wall Street celebrated a slowdown in inflation with its biggest advance since 2020. The S&P/ASX 200 wrapped up a strong week with a rise of 194 points or 2.79 pe...

ASX health stocks extend weekly gains on Friday as markets rally on back of promising US inflation figures Wound care company Avita rises 24% and biotech Antisense is up 18% for past five days Fertility company Monash IVF provides solid H1...

Avita Medical (AVH) reports a 30-per-cent bump to year-on-year revenue over the September quarter of this yearOver the three-month period, the company posted $9 million in quarterly commercial revenue compared to just under $7 million over...

Wall Street’s best night since 2020 fuelled strong gains on the ASX, powering the benchmark to its highest level since June. The S&P/ASX 200 rallied 163 points or 2.33 per cent by mid-session. The rally followed huge gains in the US...

Cynata gets Notice of Allowance from US Patent Office Proteomics secures patent in Hong Kong Ramsay Healthcare and Avita gave solid quarterly updates Cynata and Proteomics’ patents update Cynata Therapeutics (ASX:CYP) rose 8pc this mornin...

Highlights Australian shares opened higher on Friday. The ASX 200 gained in the opening trade, rising 36.10 points, or 0.52%, to 7,000.10. On Thursday, the benchmark index ended 0.5% higher at 6,964 points. Australian...

Avita Medical successfully achieved two co-primary endpoints Noxopharm received $5.011 million in R&D rebate Avita makes crucial progress in pivotal trial Avita Medical (ASX:AVH) announced that it has achieved the co-primary endpoints...